-
Carney moves to remake Canada alliances as US ties strained
-
McInnes feels 'guilt' ahead of Hearts return with Rangers
-
Serbia's students demand state media chiefs resign after poll win
-
Brazil's Lula turns 81, vows to work '24 hours a day'
-
Starc takes six as Australia fight back in South Africa decider
-
Boeing releases cautious growth plan as shares fall sharply
-
UK man offered drugged wife to strangers online for sex: court
-
Exiled Russian dissident Navalnaya warns dictators becoming 'more cunning'
-
Africa Ebola outbreak passes 10,000 cases, mostly in DR Congo
-
Bayern 'risk' reaps huge reward for Ballon d'Or winner Kane
-
EU pushes for more nations to pay to protect nature
-
Record turnout as Israeli voters deliver verdict on Netanyahu
-
Boeing reports smaller loss as it aims for stable output growth
-
Iraola says Isak 'feels the trust' after Liverpool scoring streak
-
Tech firms gain on Anthropic IPO optimism; HSBC slumps in London
-
French media protest manhandling of journalists at far-right party rally
-
Sri Lanka end England hopes with crushing win over Pakistan
-
EU seeks deportation powers for beefed up border agency
-
Dangote, Nigeria's oil tycoon rewriting Africa's story
-
Two charged with UK security offences over airbase plot: police
-
Carrick to remain Man Utd boss for Chelsea clash: reports
-
Maresca defends Donnarumma, Guehi after Man City defeat
-
Greenhouse gas levels hit new record highs in 2025: UN
-
Nordic leaders call Putin as local truce begins in Ukraine
-
Rybakina looking to clinch year-end number one in Tokyo
-
Osaka unveils crane outfit in Tokyo before win over Paolini
-
Tech firms track Wall St rally on mixed day for stock markets
-
Ronaldo in line for Portugal return after fallout with coach
-
Kane says Ballon d'Or win 'feels like a dream' as tributes pour in
-
Norway media take legal action to block Meta from using content
-
HSBC profit jumps on higher rates, lower costs
-
Bayern praise 'humble' Kane after Ballon d'Or win
-
Rams rediscover offensive balance in 35-21 victory over Raiders
-
Colts retain Daniel Jones as starter despite continued offensive struggles
-
Mercedes-Benz cuts 2026 profit outlook on tough China market
-
Madushanka wrecks Pakistan as Sri Lanka press for final slot
-
Reparations calls follow Charles on tough Caribbean trip
-
Destructive Abhishek 113 leads India to series win over New Zealand
-
Jammu and Kashmir ministers resign before planned council expansion
-
Norway, Finland leaders hold 'frank and substantive' talk with Putin
-
Germany, EU, stable investment stops despite upheaval: Merz
-
Wall Street faces earnings and Fed tests after turbulent technology-led week
-
China brands drop Mbappe for 'offending national sentiments'
-
Ukraine, Russia say US-brokered truce holding in ravaged city
-
India orders evacuations as Cyclone Arnab looms
-
Police form SIT after vehicles in Rahul Gandhi convoy collide on expressway
-
Dutch broadcaster pulls out of Eurovision over Israel 'sensitivities'
-
Delhi grants minimum monthly pay and DA to about 4,000 MCD health workers
-
Critical coal inventories affect nearly half of India’s domestic power plants
-
Ather Energy shares climb 14% after quarterly profit and expansion plan
Evolution Devices Announces First Multi-Location Clinical Sale of EvoWalk to Leading Rehabilitation Provider, Advancing National Commercialization
SAN FRANCISCO, CA / ACCESS Newswire / May 12, 2026 / Evolution Devices today announced its first multi-location clinical sale of EvoWalk to Sheltering Arms Institute, a globally recognized leader in physical rehabilitation. The deployment marks a key milestone in Evolution Devices' commercial expansion and underscores growing demand for next-generation mobility solutions in neurorehabilitation.
EvoWalk Device is Worn Just Below the Knee
EvoWalk is designed to improve gait and restore functional walking in individuals with neurological impairments. The system delivers multi-muscle stimulation to enable a more coordinated, natural walking pattern across clinical and home environments, while AI-driven data capture monitors patient progress, adherence, and outcomes to inform clinical decision-making and personalize care.
"The EvoWalk represents a meaningful advancement over our current functional electrical stimulation (FES) systems," said Christina Withers, P.T., D.P.T., P.C.S., senior manager of outpatient therapy services at Sheltering Arms Institute. "Its intuitive design streamlines setup, allowing clinicians to focus more time on patient care and outcomes, while reusable leads and electrodes eliminate per-patient supply costs and improve efficiency."
"The EvoWalk has been a valuable addition for our patient population," said Zach Crump, P.T., D.P.T., N.C.S., locomotor specialist and clinical researcher at Sheltering Arms Institute. "Rapid setup and Bluetooth connectivity improve therapist efficiency, while targeted stimulation for up to six muscle groups supports more effective gait training. Integrated metrics such as step count, gait speed, and cadence provide actionable insights to guide progress."
"This first multi-site clinical sale validates both EvoWalk and the broader need for more effective mobility solutions," said Pierluigi Mantovani, chief executive officer of Evolution Devices. "We are proud to partner with Sheltering Arms Institute, a global leader in neurorehabilitation, as we take the next step toward national commercialization and expanded patient access."
Evolution Devices plans to expand through additional clinical partnerships, broader market access, and continued investment in data-driven insights to support adoption across rehabilitation settings.
About EVOLUTION DEVICES
Evolution Devices is a neurotechnology company advancing mobility solutions for the millions of individuals living with neurological impairments. The company develops innovative, clinically grounded devices designed to restore functional movement, improve gait, and enable greater independence in real-world settings. Evolution Devices' mission is to create accessible and innovative technology to enable anyone, anywhere to receive personalized rehabilitative care, empowering their independence through access to innovative care. For more information, visit www.evolutiondevices.com.
About EVOWALK
EvoWalk is a neurotechnology solution designed to improve gait and restore functional walking for individuals with neurological impairments. Addressing foot drop in addition to calf weakness, knee hyperextension, and hip weakness, it enables a more natural, stable walking pattern in real-world settings. EvoWalk integrates adaptive stimulation with AI-driven data capture to monitor patient progress, adherence, and outcomes - providing actionable insights for clinicians. Lightweight and user-friendly, it supports consistent use and scalable deployment across home and healthcare environments.
Images and Video: LINK
Media Contact
Erica Zeidenberg
Hot Tomato Marketing
925.518.8159
[email protected]
SOURCE: Evolution Devices
View the original press release on ACCESS Newswire
L.Miller--AMWN
